171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA
Market cap: $126.1M (12/21/2025)
Price: $0.76
Announces Pricing of Public Offering
Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC
Reports Third Quarter 2025 Financial Results and Provides Business Update
Other Events
Reports Second Quarter 2025 Financial Results and Provides Business Update
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities